To contentTo navigationTo search
Logotype

News & Events

Press Releases


2024

Implantica’s RefluxStop™ procedure now available in Norway

30.01.2024
 | Other press releases
Implantica AG (publ.), a medtech company at the forefront of bringing advanced technology into the body, announces that the RefluxStop™ procedure is now available at the Akershus University Hospital in Norway.

2023

Implantica adds another RefluxStop™ center in Spain

18.12.2023
 | Other press releases
Implantica AG (publ.), a medtech company at the forefront of bringing advanced technology into the body, announces another key public hospital in Spain successfully completed its first RefluxStop™ procedures.

Implantica announces live surgery with RefluxStop™ attended by nearly 2’000 surgeons and streamed by up to 100’000 online

05.12.2023
 | Other press releases
Implantica AG (publ), a medtech company at the forefront of bringing advanced technology into the body, announces that the RefluxStop™ procedure was included in a live surgical demonstration at the 34[th] Congress of Digestive System Surgery in Rome, Italy, where nearly 90’000 were international viewers.

Implantica publishes Interim Report January – September 2023 (Q3)

22.11.2023
 | Regulatory
RefluxStop™ – Beginning of a New Era of Acid Reflux Treatment

Implantica's RefluxStop[TM], a promising new procedure for chronic acid reflux, offered for the first time in the NHS in UK

21.11.2023
 | Other press releases
Implantica AG (publ.), a medtech company at the forefront of bringing advanced technology into the body, announces that the first RefluxStop™ procedures have been successfully performed by the NHS at Imperial College Healthcare NHS Trust.

Implantica presents the third quarter 2023 on November 22 at 15:00 CET

17.11.2023
 | Other press releases
Implantica AG (publ) invites investors to a presentation of the third quarter 2023 at 15:00 CET on November 22. The interim report for the third quarter will be published at 8:00 a.m. CET on the same day.

Implantica’s RefluxStop[TM] health economic research, showing superior cost-effectiveness, has received top-recognition at ISPOR, the world’s leading European Health-Economics Conference

16.11.2023
 | Other press releases
Implantica AG (publ.), a medtech company at the forefront of bringing advanced technology into the body, presented an abstract on cost-effectiveness analysis in Sweden, which was recognized among the Top 5% Posters category for its high scientific quality at the ISPOR Europe conference 2023 (International Society for Pharmacoeconomics and Outcomes Research) in Copenhagen, Denmark.

Implantica’s RefluxStop™ makes an impact at the leading Annual European Foregut Society Meeting

15.11.2023
 | Other press releases
Implantica AG (publ.), a medtech company at the forefront of bringing advanced technology into the body, announces participation[ ]in the 3[rd] Annual EFS (European Foregut Society) Congress in Milan, Italy in early November.

Implantica takes a big step forward at its 2[nd] Annual RefluxStop™ Users Meeting

14.11.2023
 | Other press releases
Implantica AG (publ.), a medtech company at the forefront of bringing advanced technology into the body, announces a very successful 2[nd] Annual RefluxStop™ Users Meeting in Milan, Italy in early November, where top surgeons from around the world gathered for dialogue and learning on the RefluxStop™ procedure and driving positive patient outcomes.

Implantica’s RefluxStop ™[ ]made a substantial impact at the American Foregut Society (AFS)

10.10.2023
 | Other press releases
Implantica AG (publ.), a medtech company at the forefront of bringing advanced technology into the body, successfully attended the American Foregut Society (AFS) 2023 Annual Meeting held in Dallas, Texas. The meeting included a panel discussion on RefluxStop with 4 leading European KOLs and was moderated by the former president of AFS.
Load more